Cargando…

Genetic background may contribute to the latitude-dependent prevalence of dermatomyositis and anti-TIF1-γ autoantibodies in adult patients with myositis

BACKGROUND: The prevalence of dermatomyositis (DM) versus DM and polymyositis (PM) combined has been shown to be negatively associated with latitude. This observation has been attributed to increasing exposure to ultraviolet (UV) light towards the equator. In this study, we investigated whether diff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parkes, Joanna E., Rothwell, Simon, Oldroyd, Alexander, Chinoy, Hector, Lamb, Janine A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994128/ https://www.ncbi.nlm.nih.gov/pubmed/29884237 http://dx.doi.org/10.1186/s13075-018-1617-9

Ejemplares similares

Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositis
por: Megremis, Spyridon, et al.
Publicado: (2021)

Prominent dyspigmentation in a patient with dermatomyositis and TIF1-γ autoantibodies
por: Gutierrez, Daniel, et al.
Publicado: (2022)

Myositis-specific Autoantibodies Reacting to Both Tif1gamma and Mi-2 in a Patient with Juvenile Dermatomyositis
por: TAKEZAKI, Daiki, et al.
Publicado: (2020)

1. TIF1-γ associated dermatomyositis
por: Waller, Rosemary, et al.
Publicado: (2019)

Autoantibodies to transcription intermediary factor (TIF)1β associated with dermatomyositis
por: Satoh, Minoru, et al.
Publicado: (2012)

The Role of Myositis-Specific Autoantibodies in the Dermatomyositis Spectrum
por: Marasandra Ramesh, Harshita, et al.
Publicado: (2022)

Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
por: Nakanishi, Yu, et al.
Publicado: (2020)

Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodies
por: Okiyama, Naoko, et al.
Publicado: (2019)

A unique case of dermatomyositis associated with anti-TIF1γ antibody and chondrosarcoma
por: Dziwis, Jennifer, et al.
Publicado: (2019)

Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy
por: Harada, Yumi, et al.
Publicado: (2022)

Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence
por: Ferronato, Marco, et al.
Publicado: (2023)

Multiple myositis-specific autoantibodies in dermatomyositis: 2 cases and review of the literature
por: Narayan, Neha, et al.
Publicado: (2022)

Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis
por: Cruellas, Marcela Gran Pina, et al.
Publicado: (2013)

Clinical significance of myositis-specific autoantibody profiles in Japanese patients with polymyositis/dermatomyositis
por: Temmoku, Jumpei, et al.
Publicado: (2019)

Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1-γ-Positive Dermatomyositis
por: Wu, Chih-Feng, et al.
Publicado: (2023)

ELISA, protein immunoprecipitation and line blot assays for anti-TIF1-gamma autoantibody detection in cancer-associated dermatomyositis
por: Selickaja, Sandra, et al.
Publicado: (2022)

Geographical Latitude Remains as an Important Factor for the Prevalence of Some Myositis Autoantibodies: A Systematic Review
por: Aguilar-Vazquez, Andrea, et al.
Publicado: (2021)

Genetics in inclusion body myositis
por: Rothwell, Simon, et al.
Publicado: (2017)

Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria
por: To, Fergus, et al.
Publicado: (2019)

Comments: Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis
por: Ferreira, Bruno Silva de Araujo, et al.
Publicado: (2022)

NanoString technology distinguishes anti‐TIF‐1γ(+) from anti‐Mi‐2(+) dermatomyositis patients
por: Preusse, Corinna, et al.
Publicado: (2021)

Marked Improvement of Anti-TIF1-γ Antibody-Positive Dermatomyositis After Chemoradiotherapy to Relevant Nasopharyngeal Cancer
por: Tomita, Natsuo, et al.
Publicado: (2021)

The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody–positive dermatomyositis
por: Oldroyd, Alexander, et al.
Publicado: (2019)

The myositis clinical phenotype associated with anti-Zo autoantibodies: a case series of nine UK patients
por: Tansley, Sarah L, et al.
Publicado: (2020)

Muscle Biopsy Findings in Combination With Myositis‐Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis
por: Deakin, Claire T., et al.
Publicado: (2016)

Patient-centred standards of care for adults with myositis
por: Lilleker, James B., et al.
Publicado: (2017)

The Roles of TIF1γ in Cancer
por: Yu, Chengpeng, et al.
Publicado: (2019)

Anti‐TIF1γ antibody‐positive dermatomyositis associated with durvalumab administration in a patient with lung and oesophageal cancers
por: Imai, Ryosuke, et al.
Publicado: (2021)

Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer
por: Betteridge, Zoe E., et al.
Publicado: (2018)

Clinical Features and Cutaneous Manifestations of Juvenile and Adult Patients of Dermatomyositis Associated with Myositis-Specific Autoantibodies
por: Okiyama, Naoko
Publicado: (2021)

Genetics of idiopathic inflammatory myopathies: insights into disease pathogenesis
por: Rothwell, Simon, et al.
Publicado: (2019)

Comment on: The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody–positive dermatomyositis: Reply
por: Oldroyd, Alexander, et al.
Publicado: (2019)

Long‐term strength and functional status in inclusion body myositis and identification of trajectory subgroups
por: Oldroyd, Alexander G. S., et al.
Publicado: (2020)

OA29 Blotting-based assays under-detected TIF1-gamma and NXP2 autoantibodies compared to immunoprecipitation in Juvenile Dermatomyositis cohorts
por: Nguyen, Huong D, et al.
Publicado: (2022)

Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups
por: Rothwell, Simon, et al.
Publicado: (2019)

The cancer immunotherapy environment may confound the utility of anti-TIF-1γ in differentiating between paraneoplastic and treatment-related dermatomyositis. Report of a case and review of the literature
por: Zarkavelis, George, et al.
Publicado: (2020)

Anti-TIF1γ antibody predicted malignancy of thymic tumor with dermatomyositis as an “autoimmune tumor marker”: A case report
por: Karino, Kohei, et al.
Publicado: (2018)

Clinical Manifestations and Myositis-Specific Autoantibodies Associated with Physical Dysfunction after Treatment in Polymyositis and Dermatomyositis: An Observational Study of Physical Dysfunction with Myositis in Japan
por: Kawasumi, Hidenaga, et al.
Publicado: (2016)

Juvenile dermatomyositis (JDM) sine myositis
por: Schuetz, C, et al.
Publicado: (2011)

Dermatomyositis Sine Myositis with Membranoproliferative Glomerulonephritis
por: Owlia, Mohammad Bagher, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gqm86s0ruqqmve771qd8d0ef4c